Suppr超能文献

地肤叶提取物对 45%高热量饲料喂养小鼠的抗糖尿病肥胖作用。

Anti-Diabetic Obesity Effects of Matsum Leaf Extract on 45% Kcal High-Fat Diet-Fed Mice.

机构信息

Research Institute, Nutracore Co., Ltd., Gwanggyo SK Viewlake A-3206, Beobjo-Ro 25, Yeongtong-Gu, Suwon, Gyeonggi-Do 16514, Korea.

Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, 130 Dongdeok-ro, Jung-gu, Daegu 41944, Korea.

出版信息

Nutrients. 2020 Sep 16;12(9):2837. doi: 10.3390/nu12092837.

Abstract

The present study examined the effects of Wasabi leaf (WL) on 45% Kcal high-fat diet (HFD)-fed mild diabetic obese mice. In particular, the hepatoprotective (i.e., liver weight, histopathology of liver, serum aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyltransferase) effects of 12 weeks of continuous oral administration of 250 mg/kg metformin, and 200, 100, or 50 mg/kg WL were investigated. In addition, the hypolipidemic (i.e., serum triglyceride, total cholesterol, high-density lipoprotein-cholesterol, and low-density lipoprotein levels), hypoglycemic (i.e., glycated hemoglobin, blood glucose and insulin levels, pancreatic weight, and immunohistochemical-histopathological analysis of the pancreas), and anti-obesity effects (i.e., body weight, mean food consumption, total and abdominal body fat mass, periovarian fat weight, and histopathology of the periovarian and abdominal wall adipocytes) were monitored. The liver and general antioxidant defense systems were also assessed by lipid metabolism-related gene expression. All diabetes manifestations and related complications, including obesity and non-alcoholic fatty liver disease (NAFLD), were dose-dependently reduced after 84 days of oral treatment with metformin or each of the three dosages of WL. In particular, 50 mg/kg WL showed effective suppression effects against HFD-induced diabetes and related complications of obesity, NAFLD, and hyperlipidemia, comparable to the effects of metformin.

摘要

本研究考察了山葵叶(WL)对 45%大卡高脂肪饮食(HFD)喂养的轻度糖尿病肥胖小鼠的影响。特别是,连续口服 250mg/kg 二甲双胍、200、100 或 50mg/kg WL 12 周对肝保护(即肝重、肝组织病理学、血清天冬氨酸转氨酶、丙氨酸转氨酶和γ-谷氨酰转移酶)、降血脂(即血清甘油三酯、总胆固醇、高密度脂蛋白胆固醇和低密度脂蛋白水平)、降血糖(即糖化血红蛋白、血糖和胰岛素水平、胰腺重量和胰腺的免疫组化组织病理学分析)和抗肥胖作用(即体重、平均食物消耗、全身和腹部体脂肪量、卵巢周围脂肪重量以及卵巢周围和腹壁脂肪细胞的组织病理学)进行了研究。还通过脂质代谢相关基因表达评估了肝脏和一般抗氧化防御系统。在口服治疗 84 天后,所有糖尿病表现和相关并发症,包括肥胖和非酒精性脂肪肝(NAFLD),均与二甲双胍或 WL 的三种剂量呈剂量依赖性降低。特别是,50mg/kg WL 对 HFD 诱导的糖尿病及其肥胖、NAFLD 和高脂血症相关并发症具有有效抑制作用,与二甲双胍相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6177/7551095/34f1ab36d09d/nutrients-12-02837-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验